Sustained virological response after early discontinuation of HCV treatment

被引：0
|
作者：
Flisiak, Robert [1 ]
Bska-Michaluk, Dorota Zarebska [2 ]
Janczewska, Ewa [3 ]
Parfieniuk-Kowerda, Anna [1 ]
Mazur, Wlodzimierz [4 ]
Sitko, Marek [5 ]
Janocha-Litwin, Justyna [6 ]
Krygier, Rafal [7 ]
Lorenc, Beata [8 ]
Piekarska, Anna [9 ]
Sobala-Szczygiel, Barbara [10 ]
Dobrowolska, Krystyna [2 ]
Socha, Lukasz [11 ]
Jaroszewicz, Jerzy [10 ]
机构：
[1] Med Univ Bialystok, Bialystok, Poland
[2] Jan Kochanowski Univ, Kielce, Poland
[3] ID Clin, Myslowice, Poland
[4] Med Univ Silesia, Chorzow, Poland
[5] Jagiellonian Univ, Krakow, Poland
[6] Wroclaw Med Univ, Wroclaw, Poland
[7] NZOZ Gemini, Zychlin, Poland
[8] Med Univ Gdansk, Gdansk, Poland
[9] Med Univ Lodz, Lodz, Poland
[10] Med Univ Silesia, Bytom, Poland
[11] Pomeranian Med Univ, Szczecin, Poland
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-389
引用
收藏
页码：S821 / S821
页数：1
相关论文
共 50 条
  • [21] THE RISK OF HCV RECURRENCE IN HCV INFECTED PATIENTS TREATED WITH DAA AFTER ACHIEVING A SUSTAINED VIROLOGICAL RESPONSE: A COMPREHENSIVE ANALYSIS
    Huang, Peng
    Wang, Yan
    Holmes, Jacinta A.
    Shao, Tuo
    Cheng, Zhimeng
    Yan, Jiuliang
    Tian, Yanzhang
    Yu, Rongbin
    Jeyarajan, Andre
    Zhu, Chuanwu
    Yang, Sheng
    Lin, Wenyu
    Chung, Raymond T.
    HEPATOLOGY, 2020, 72 : 545A - 545A
  • [22] Sustained virological response to treatment in 100% of patients recently infected, nosocomially, with HCV genotype 2
    Sikuler, E
    Kaspa, RT
    Shemer-Avni, Y
    Delgado, J
    Zilberman, D
    Fich, A
    Baruch, Y
    Hyam, E
    HEPATOLOGY, 2005, 42 (04) : 678A - 679A
  • [23] EARLY VIROLOGICAL RESPONSE AND ABSENCE OF DIABETES ARE ASSOCIATED WITH SUSTAINED VIROLOGICAL RESPONSE TO HEPATITIS C TREATMENT AFTER LIVER TRANSPLANTATION IN PATIENTS WITH CYCLOSPORINE A BASED IMMUNOSUPPRESSION
    Hurtova, Monika
    Fourti, Mohamed
    Mediahed, Nessrine
    Samuel, Didier
    Neau-Cransac, Martine
    Calmus, Yvon
    Pageaux, Georges Philippe
    Pageaux, Philippe
    Lorho, Richard
    Vanlemmens, Claire
    Laurent, Alexis
    Decaens, Thomas
    Duvoux, Christophe
    HEPATOLOGY, 2008, 48 (04) : 581A - 581A
  • [24] Early virological response to daily induction interferon treatment in chronic HCV infection
    Rossini, A
    Biasi, L
    Artini, M
    Almerighi, C
    Massari, M
    Levrero, M
    Cariani, E
    Radaeli, E
    HEPATOLOGY, 1998, 28 (04) : 372A - 372A
  • [25] Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis
    Persico, Marcello
    Rosato, Valerio
    Aglitti, Andrea
    Precone, Davide
    Corrado, Mariano
    De Luna, Antonio
    Morisco, Filomena
    Camera, Silvia
    Federico, Alessandro
    Dallio, Marcello
    Claar, Ernesto
    Caporaso, Nicola
    Masarone, Mario
    ANTIVIRAL THERAPY, 2018, 23 (02) : 129 - 138
  • [26] Vitamin B12 increases the sustained virological response in HCV
    Claire Greenhill
    Nature Reviews Gastroenterology & Hepatology, 2012, 9 (9) : 490 - 490
  • [27] Recombinant HBV vaccine enhances the rate of sustained virological response when early initiated after anti-HCV combination therapy
    Hanafy, Amr Shaaban
    Farag, Alaa Ahmad
    Hassanin, Hassan Mahmoud
    Hassaneen, Ahmad Mahmoud
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (01) : 86 - 93
  • [28] PEG-INTERFERON PLUS RIBAVIRIN IN COMPENSATED HCV CIRRHOSIS WITH PORTAL HYPERTENSION: THE ROLE OF RAPID AND EARLY VIROLOGICAL RESPONSE IN PREDICTING THE SUSTAINED VIROLOGICAL RESPONSE
    Calvaruso, Vincenza
    Di Marco, Vito
    Almasio, Piero L.
    De Lisi, Stefania
    Ferraro, Donatello
    Pizzillo, Paola
    Peralta, Sergio
    Craxi, Anto-nio
    HEPATOLOGY, 2009, 50 (04) : 725A - 725A
  • [29] Early on-treatment viral load and baseline METAVIR score: improved prediction of sustained virological response in HCV genotype 1 patients
    Crawford, Darrell H. G.
    Dore, Gregory J.
    Sievert, William
    Cheng, Wendy S. C.
    Weltman, Martin
    McCaughan, Geoffrey
    Rawlinson, William
    Marks, Philippa S.
    Yoshihara, Motoko
    Rizkalla, Bishoy
    Roberts, Stuart K.
    ANTIVIRAL THERAPY, 2012, 17 (05) : 849 - 854
  • [30] RISK FACTORS AND CHARACTERISTICS OF HEPATOCELLULAR CARCINOMA OCCURING IN HCV CIRRHOTIC PATIENTS AFTER SUSTAINED VIROLOGICAL RESPONSE
    Payance, A.
    Goutte, N.
    Clair, E.
    Paradis, V.
    Bouattour, M.
    Vullierme, M. -P.
    Castelnau, C.
    Boyer, N.
    Farges, O.
    Asselah, T.
    Durand, F.
    Bedossa, P.
    Marcellin, P.
    Castera, L.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S320 - S320
12345